Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings

Seeking AlphaDec 21, 2024 04:00

Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesDec 16, 2024 20:25 · Ratings

Watching Neumora Therapeutics; Shares See Volume To The Upside, Traders Circulate Unconfirmed Analyst Comments Saying "We Remain Buyers Into NMRA's MDD Data, Citing JNJ's Early Completion Of Phase III Aticaprant Study Efficacy And Safety Profile,...

BenzingaDec 7, 2024 03:38

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 3, 2024 01:35

Positive Outlook on Neumora Therapeutics Driven by Navacaprant's Potential in MDD Treatment

TipRanksNov 25, 2024 15:35

Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)

TipRanksNov 22, 2024 19:51 · Ratings